Dermatan Sulfate

endothelial cell specific molecule 1 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33742537 The significance of endocan immunohistochemical expression in chronic plaque psoriasis. 2022 Jan 1
2 34953930 Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. 2022 Jan 1
3 35454082 Endocan in Acute Leukemia: Current Knowledge and Future Perspectives. 2022 Mar 24 1
4 34109132 Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach. 2021 2
5 32710940 Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. 2020 Oct 1
6 20821239 ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. 2011 Mar 2
7 20581009 Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. 2010 Nov 2
8 16168566 Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. 2006 Jan 2
9 16899604 Endocan expression and relationship with survival in human non-small cell lung cancer. 2006 Aug 1 1
10 11590178 Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. 2001 Dec 21 3